Ruth Adams
Chief Tech/Sci/R&D Officer at NUVALENT, INC.
Ruth Adams active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NUVALENT, INC. | Chief Tech/Sci/R&D Officer | 01/11/2020 | - |
Career history of Ruth Adams
Former positions of Ruth Adams
| Companies | Position | Start | End |
|---|---|---|---|
Vigeo Therapeutics, Inc.
 Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - | - |
Training of Ruth Adams
| The University of Southampton | Undergraduate Degree |
Statistics
International
| United States | 3 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NUVALENT, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Ruth Adams
- Experience
